Literature DB >> 28592539

HIV-1 Epitope Variability Is Associated with T Cell Receptor Repertoire Instability and Breadth.

Arumugam Balamurugan1, Deon Claiborne2, Hwee L Ng1, Otto O Yang3,4,5,6.   

Abstract

Mutational escape of HIV-1 from HIV-1-specific CD8+ T lymphocytes (CTLs) is a major barrier for effective immune control. Each epitope typically is targeted by multiple clones with distinct T cell receptors (TCRs). While the clonal repertoire may be important for containing epitope variation, determinants of its composition are poorly understood. We investigate the clonal repertoire of 29 CTL responses against 23 HIV-1 epitopes longitudinally in nine chronically infected untreated subjects with plasma viremia of <3,000 RNA copies/ml over 17 to 179 weeks. The composition of TCRs targeting each epitope varied considerably in stability over time, although clonal stability (Sorensen index) was not significantly time dependent within this interval. However, TCR stability inversely correlated with epitope variability in the Los Alamos HIV-1 Sequence Database, consistent with TCR evolution being driven by epitope variation. Finally, a robust inverse correlation of TCR breadth against each epitope versus epitope variability further suggested that this variability drives TCR repertoire diversification. In the context of studies demonstrating rapidly shifting HIV-1 sequences in vivo, our findings support a variably dynamic process of shifting CTL clonality lagging in tandem with viral evolution and suggest that preventing escape of HIV-1 may require coordinated direction of the CTL clonal repertoire to simultaneously block escape pathways.IMPORTANCE Mutational escape of HIV-1 from HIV-1-specific CD8+ T lymphocytes (CTLs) is a major barrier to effective immune control. The number of distinct CTL clones targeting each epitope is proposed to be an important factor, but the determinants are poorly understood. Here, we demonstrate that the clonal stability and number of clones for the CTL response against an epitope are inversely associated with the general variability of the epitope. These results show that CTLs constantly lag epitope mutation, suggesting that preventing HIV-1 escape may require coordinated direction of the CTL clonal repertoire to simultaneously block escape pathways.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  cytotoxic T lymphocytes; human immunodeficiency virus

Mesh:

Substances:

Year:  2017        PMID: 28592539      PMCID: PMC5533926          DOI: 10.1128/JVI.00771-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia.

Authors:  Otto O Yang; Eric S Daar; Hwee L Ng; Roger Shih; Beth D Jamieson
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-18       Impact factor: 2.205

2.  Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants.

Authors:  Brenna C Simons; Scott E Vancompernolle; Rita M Smith; Jie Wei; Louise Barnett; Shelly L Lorey; Dirk Meyer-Olson; Spyros A Kalams
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Authors:  P Borrow; H Lewicki; X Wei; M S Horwitz; N Peffer; H Meyers; J A Nelson; J E Gairin; B H Hahn; M B Oldstone; G M Shaw
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

4.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

5.  De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.

Authors:  Todd M Allen; Xu G Yu; Elizabeth T Kalife; Laura L Reyor; Mathias Lichterfeld; Mina John; Michael Cheng; Rachel L Allgaier; Stanley Mui; Nicole Frahm; Galit Alter; Nancy V Brown; Mary N Johnston; Eric S Rosenberg; Simon A Mallal; Christian Brander; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.

Authors:  S A Kalams; P J Goulder; A K Shea; N G Jones; A K Trocha; G S Ogg; B D Walker
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Rapid T cell receptor delineation reveals clonal expansion limitation of the magnitude of the HIV-1-specific CD8+ T cell response.

Authors:  Arumugam Balamurugan; Hwee L Ng; Otto O Yang
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

8.  Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

Authors:  Sampa Santra; Hua-Xin Liao; Ruijin Zhang; Mark Muldoon; Sydeaka Watson; Will Fischer; James Theiler; James Szinger; Harikrishnan Balachandran; Adam Buzby; David Quinn; Robert J Parks; Chun-Yen Tsao; Angela Carville; Keith G Mansfield; George N Pavlakis; Barbara K Felber; Barton F Haynes; Bette T Korber; Norman L Letvin
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

9.  Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection.

Authors:  Geraldine M A Gillespie; Guillaume Stewart-Jones; Jaya Rengasamy; Tara Beattie; Job J Bwayo; Francis A Plummer; Rupert Kaul; Andrew J McMichael; Philippa Easterbrook; Tao Dong; E Yvonne Jones; Sarah L Rowland-Jones
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

10.  Definition of the viral targets of protective HIV-1-specific T cell responses.

Authors:  Beatriz Mothe; Anuska Llano; Javier Ibarrondo; Marcus Daniels; Cristina Miranda; Jennifer Zamarreño; Vanessa Bach; Rosario Zuniga; Susana Pérez-Álvarez; Christoph T Berger; Maria C Puertas; Javier Martinez-Picado; Morgane Rolland; Marilu Farfan; James J Szinger; William H Hildebrand; Otto O Yang; Victor Sanchez-Merino; Chanson J Brumme; Zabrina L Brumme; David Heckerman; Todd M Allen; James I Mullins; Guadalupe Gómez; Philip J Goulder; Bruce D Walker; Jose M Gatell; Bonaventura Clotet; Bette T Korber; Jorge Sanchez; Christian Brander
Journal:  J Transl Med       Date:  2011-12-07       Impact factor: 5.531

View more
  3 in total

Review 1.  Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19.

Authors:  Hassan A Alhazmi; Asim Najmi; Sadique A Javed; Shahnaz Sultana; Mohammed Al Bratty; Hafiz A Makeen; Abdulkarim M Meraya; Waquar Ahsan; Syam Mohan; Manal M E Taha; Asaad Khalid
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

2.  Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells.

Authors:  Jodi Wong; Stephen Yiu Chuen Choi; Rongrong Liu; Eddie Xu; James Killam; Peter W Gout; Yuzhuo Wang
Journal:  Front Cell Infect Microbiol       Date:  2019-02-12       Impact factor: 5.293

3.  CD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infection.

Authors:  Kai Qin; Sushma Boppana; Victor Y Du; Jonathan M Carlson; Ling Yue; Dario A Dilernia; Eric Hunter; Robbie B Mailliard; Simon A Mallal; Anju Bansal; Paul A Goepfert
Journal:  PLoS Pathog       Date:  2019-08-09       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.